EX-99.(D)(3) 10 dex99d3.htm CONFIDENTIALITY AND EXCLUSIVITY AGREEMENT Exhibit (d)(3) CONFIDENTIALITY AND EXCLUSIVITY AGREEMENTConfidentiality and Exclusivity Agreement • May 5th, 2020 • Delaware
Contract Type FiledMay 5th, 2020 JurisdictionThis CONFIDENTIALITY AND EXCLUSIVITY AGREEMENT (this “Agreement”) is dated as of August 3, 2006 and is by and between Myogen, Inc., a Delaware corporation (the “Company”), and Gilead Sciences, Inc., a Delaware corporation (“Recipient”). Recipient and the Company are sometimes collectively referred to herein as the “Parties” and individually as a “Party.” Certain capitalized terms used herein have the meanings set forth in Section 9.
CONFIDENTIALITY AND EXCLUSIVITY AGREEMENTConfidentiality and Exclusivity Agreement • October 16th, 2006 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledOctober 16th, 2006 Company Industry JurisdictionThis CONFIDENTIALITY AND EXCLUSIVITY AGREEMENT (this “Agreement”) is dated as of August 3, 2006 and is by and between Myogen, Inc., a Delaware corporation (the “Company”), and Gilead Sciences, Inc., a Delaware corporation (“Recipient”). Recipient and the Company are sometimes collectively referred to herein as the “Parties” and individually as a “Party.” Certain capitalized terms used herein have the meanings set forth in Section 9.